Unknown

Dataset Information

0

The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism.


ABSTRACT: Dyslipidemia has been frequently observed among individuals infected with human immunodeficiency virus type 1 (HIV-1), and factors related to HIV-1, the host, and antiretroviral therapy (ART) are involved in this phenomenon. This study reviews the roles of genetic polymorphisms, HIV-1 infection, and highly active antiretroviral therapy (HAART) in lipid metabolism. Lipid abnormalities can vary according to the HAART regimen, such as those with protease inhibitors (PIs). However, genetic factors may also be involved in dyslipidemia because not all patients receiving the same HAART regimen and with comparable demographic, virological, and immunological characteristics develop variations in the lipid profile. Polymorphisms in a large number of genes are involved in the synthesis of structural proteins, and enzymes related to lipid metabolism account for variations in the lipid profile of each individual. As some genetic polymorphisms may cause dyslipidemia, these allele variants should be investigated in HIV-1-infected patients to identify individuals with an increased risk of developing dyslipidemia during treatment with HAART, particularly during therapy with PIs. This knowledge may guide individualized treatment decisions and lead to the development of new therapeutic targets for the treatment of dyslipidemia in these patients.

SUBMITTER: de Almeida ER 

PROVIDER: S-EPMC3844249 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism.

de Almeida Elaine Regina Delicato ER   Reiche Edna Maria Vissoci EM   Kallaur Ana Paula AP   Flauzino Tamires T   Watanabe Maria Angelica Ehara MA  

BioMed research international 20131112


Dyslipidemia has been frequently observed among individuals infected with human immunodeficiency virus type 1 (HIV-1), and factors related to HIV-1, the host, and antiretroviral therapy (ART) are involved in this phenomenon. This study reviews the roles of genetic polymorphisms, HIV-1 infection, and highly active antiretroviral therapy (HAART) in lipid metabolism. Lipid abnormalities can vary according to the HAART regimen, such as those with protease inhibitors (PIs). However, genetic factors m  ...[more]

Similar Datasets

| S-EPMC111953 | biostudies-literature
| S-EPMC6299522 | biostudies-other
| S-EPMC5391252 | biostudies-literature
| S-EPMC1470792 | biostudies-other
| S-EPMC1395369 | biostudies-literature
| S-EPMC113179 | biostudies-literature
| S-EPMC240902 | biostudies-other
| S-EPMC136917 | biostudies-literature
| S-EPMC4161799 | biostudies-literature
| S-EPMC6235802 | biostudies-literature